Innovations in Chemotherapy Personalization, Cell Transplants, Multi-drug Resistance Studies, and Adult Stem Cell Regeneration
Innovations in Chemotherapy Personalization, Cell Transplants, Multi-drug Resistance Studies, and Adult Stem Cell Regeneration
08-Jun-2018
Global
$250.00
Special Price $187.50 save 25 %
Description
The Genetic Technology TechVision Opportunity Engine (TOE) presents trends across chemotherapy personalization, cell transplantation, multi-drug resistance studies, and adult stem cell regeneration. The corresponding clinical trials scenario related to monoclonal antibody drugs for autoimmune diseases is also depicted.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Keywords: Chemotherapy personalization, cell transplants, multi-drug resistance studies, adult stem cell regeneration, chemotherapy genetic interaction map, personalized treatment, pancreatic cell transplant, vascularization, Acinetobacter baumannii, stem cells
Table of Contents
Recent Advances in Chemotherapy Personalization, Cell Transplants, Multi-drug Resistance Studies and Adult Stem Cell Regeneration
- Chemotherapy Genetic Interaction Map for Personalized Treatment
- Pancreatic Cell Transplant Capable of Vascularization
- Decoding Acinetobacter Baumannii’s Multi-drug Resistance
- Adult Stem Cell Regeneration by Fasting
Clinical Trial Analysis and Key Contacts
- Clinical Trial Analysis of Monoclonal Antibody Drugs for Autoimmune Diseases
- Key Contacts
Related Research
Popular Topics
No Index | No |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | D758-00-7D-00-00 |
Is Prebook | No |
Ti Codes | D753,D904,D913,D91A,D91B,D932,D933,D935 |